⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LIMN News
Liminatus Pharma, Inc. Class A Common Stock
Form 8-K
sec.gov
LIMN
LIMNW
Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline
globenewswire.com
LIMN
Form 8-K
sec.gov
LIMN
LIMNW
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds
globenewswire.com
LIMN
Form 8-K
sec.gov
LIMNW
LIMN
Liminatus Pharma Announces Nasdaq Delisting Notification
globenewswire.com
LIMN
Form 8-K
sec.gov
LIMNW
LIMN
Form 8-K
sec.gov
LIMN
LIMNW
Form 8-K
sec.gov
LIMNW
LIMN
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
globenewswire.com
LIMN